Filing Details

Accession Number:
0001127602-20-001938
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-17 16:31:43
Reporting Period:
2020-01-15
Accepted Time:
2020-01-17 16:31:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194413 J Larry Merlo One Cvs Drive
Woonsocket RI 02895-
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-15 314,713 $54.53 703,497 No 4 M Direct
Common Stock Disposition 2020-01-15 266,476 $74.79 437,021 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2020-01-15 314,713 $0.00 314,713 $54.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-04-01 2020-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 391,070 Indirect By Trust As Beneficiary
Common Stock (Restricted) 81,879 Direct
Esop Common Stock 7,208 Indirect By ESOP
Stock Unit 665,529 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Phantom Stock Credits $1.00 5,159 5,159 Direct
Common Stock Stock Option $74.29 2015-04-01 2021-04-01 335,697 335,697 Direct
Common Stock Stock Option $102.26 2016-04-01 2022-04-01 273,929 273,929 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 286,787 286,787 Direct
Common Stock Stock Option $78.05 2018-04-03 2024-04-03 338,105 338,105 Direct
Common Stock Stock Option $62.21 2019-04-01 2025-04-01 394,091 394,091 Direct
Common Stock Stock Option $54.19 2020-04-01 2029-04-01 545,419 545,419 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
5,159 5,159 Direct
2021-04-01 335,697 335,697 Direct
2022-04-01 273,929 273,929 Direct
2023-04-01 286,787 286,787 Direct
2024-04-03 338,105 338,105 Direct
2025-04-01 394,091 394,091 Direct
2029-04-01 545,419 545,419 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares.
  2. Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $73.99 and $75.55 per share.
  3. Option became exercisable in four equal annual installments, commencing 4/1/2014.
  4. Each share credit is equivalent to one share; 1-for-1 conversion.
  5. Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  6. Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  7. Option became exercisable in four equal annual installments, commencing 4/1/2015.
  8. Option became exercisable in four equal annual installments, commencing 4/1/2016.
  9. Option became exercisable in four equal annual installments, commencing 4/1/2017.
  10. Option became exercisable in four equal annual installments, commencing 4/3/2018.
  11. Option became exercisable in four equal annual installments, commencing 4/1/2019.
  12. Option becomes exercisable in four equal annual installments, commencing 4/1/2020.